GlassScriptPhysician profile
Lowell T Ku
NPI 1184642274
$12,235.27
in general payments reported to CMS, 2019-2025
10 companies · $1,447 in 2025
The $1,447 reported for 2025 was more than what 92% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,854 · 2020: $1,844 · 2021: $277 · 2022: $283 · 2023: $1,170 · 2024: $1,360 · 2025: $1,447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,975 · Food and Beverage: $1,502 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,974.85 |
| Food and Beverage | $1,502.34 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $6,136.73 | 2019-2025 | Menopur |
| Merck Sharp & Dohme LLC | $3,980.18 | 2019-2021 | |
| Hamilton Thorne, INC. | $500.00 | 2025 | Soft-Pass |
| Organon LLC | $480.30 | 2021-2025 | Pregnyl, Follistim Aq, Ganirelix Acetate |
| Coopersurgical, INC. | $400.92 | 2020-2025 | Stripper |
| Emd Serono, INC. | $345.66 | 2021-2025 | |
| Abbvie INC. | $180.05 | 2019-2021 | |
| Covidien LP | $150.58 | 2019 | |
| Hologic Sales and Service, LLC | $35.82 | 2019-2022 | |
| Mission Pharmacal Company | $25.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lowell Ku listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.